Cabaletta Bio (CABA) Net Cash Flow (2018 - 2025)

Cabaletta Bio's Net Cash Flow history runs 8 years deep, the most recent figure standing at $22.8 million for Q4 2025.

• In Q4 2025, Net Cash Flow rose 443.86% year-over-year to $22.8 million; the TTM figure through Dec 2025 stood at -$81.0 million (down 176.86% YoY), while the FY2025 annual figure was -$81.0 million, down 176.86% from the prior year.
• Net Cash Flow was $22.8 million for Q4 2025 at Cabaletta Bio, up from -$85.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $77.7 million in Q4 2023 to a low of -$85.4 million in Q3 2025.
• Historically, Net Cash Flow has averaged -$922300.0 across 5 years, with a median of $2.8 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Net Cash Flow jumped 649.01% in 2021, then slumped 1409.37% in 2022.
• A 5-year view of Net Cash Flow shows it stood at $4.0 million in 2021, then soared by 416.0% to $20.4 million in 2022, then surged by 280.24% to $77.7 million in 2023, then plunged by 108.52% to -$6.6 million in 2024, then surged by 443.86% to $22.8 million in 2025.
• The last three Net Cash Flow figures came in at $22.8 million (Q4 2025), -$85.4 million (Q3 2025), and $13.8 million (Q2 2025), per Business Quant data.